The alpha-glucosidase inhibitor miglitol for the treatment of type 2 diabetes mellitus in the doctor's office;Der Alpha-Glukosidasehemmer Miglitol zur Therapie des Diabetes mellitus Typ 2 in der Praxis.

Fortschritte der Medizin. Originalien

Volumn 119 Suppl 2, Issue , 2001, Pages 55-61

  Fehmann, H C ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA GLUCOSIDASE; ANTIDIABETIC AGENT; DRUG DERIVATIVE; GLUCOSAMINE; GLYCOSYLATED HEMOGLOBIN; IMINOSUGAR; MIGLITOL; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; BLOOD; BODY MASS; BODY WEIGHT; COMPARATIVE STUDY; DRUG ANTAGONISM; EVALUATION; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; MALE; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; SAFETY; TIME;

ADULT; AGED; AGED, 80 AND OVER; ALPHA-GLUCOSIDASES; BLOOD GLUCOSE; BODY MASS INDEX; BODY WEIGHT; DIABETES MELLITUS, TYPE 2; FEMALE; GLUCOSAMINE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIC AGENTS; IMINO PYRANOSES; MALE; MIDDLE AGED; SAFETY; TIME FACTORS; TRIGLYCERIDES;

EID: 14144253223     PISSN: None     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)